This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Philadelphia Native And Author Of Book On Healthcare Industry Headlines Expert Panel At The Wharton Health Care Business Conference

PHILADELPHIA, Feb. 7, 2013 /PRNewswire/ -- It's no secret that the healthcare landscape is tough and getting tougher.  In the U.S., we see the implementation of the healthcare reform against the background of a fragile economic recovery, creating a tumultuous environment for the entire sector.  Philadelphia native and author of Healthcare at a Turning Point: A Roadmap for Change Michael Abrams will moderate a panel discussion on how recent changes in the legal and regulatory landscape are impacting each sector of the industry at the Wharton Health Care Business Conference on February 15. 

Michael will be joined by panelists representing pharmaceuticals, medical devices, payers and healthcare IT to discuss how both domestic and global trends are impacting the entire healthcare sector.  This discussion will be followed by a Q&A with Michael and panelists Mitchell Higashi, PhD, Chief Economist, GE Healthcare, Joseph Leveque, MD, Vice President, Head of US Medical Oncology, Bristol-Myers Squibb, Matt Manders, President, Regional and Operations, Cigna, and Emad Rizk, MD, President McKesson Health Solutions, McKesson Corporation.  

This event is open to the media.

19 th Annual Wharton Health Care Business Conference     Hyatt at the Bellevue     February 15, 2013     11:15am-12:30pm

About Michael Abrams

Over the past 25 years, Michael has built a portfolio of strategy and business performance successes as both an internal and external consultant for Fortune 500 corporations on a global basis. Michael is well known for his expertise in the emerging demand for economic and clinical value, and has helped clients develop processes and capabilities to successfully compete in highly dynamic markets. Michael has written extensively on the need for integrated, systemic solutions to the challenges facing the healthcare industry, and has co-authored two books, including Healthcare at a Turning Point: A Roadmap for Change.

About Numerof & Associates:

NAI is a strategy consulting firm that develops customized, market-based solutions for strategic and operational challenges of organizations in industries undergoing significant transition. Working globally across the healthcare industry with clients in delivery, pharmaceuticals, medical devices and diagnostics, payers, and policy, NAI brings a unique cross-disciplinary approach to a broad range of engagements designed to sharpen strategic focus, increase revenues, reduce costs and risk, and enhance customer value. Visit us at www.nai-consulting.com.

SOURCE Michael Abrams

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,181.85 -346.18 -2.09%
S&P 500 1,930.21 -41.97 -2.13%
NASDAQ 4,689.8780 -86.63 -1.81%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs